<DOC>
	<DOCNO>NCT03011957</DOCNO>
	<brief_summary>MATCH observation study HIV-infected adult effective antiretroviral therapy ( ART ) demographically match uninfected adult evaluate muscle aging .</brief_summary>
	<brief_title>Biomarkers Muscle Function Aging Chronic HIV Infection</brief_title>
	<detailed_description>MATCH non-randomized observational longitudinal study . We recruit HIV infect adult ( 50 65 year old ) demographically match uninfected control subject follow 4 year course 5 year study . The targeted age range 50-65 chosen evaluate age HIV infected individual risk early frailty United States . All subject undergo blood draw physical function assessment , subset undergo CT scan muscle muscle biopsy take . A substudy perform subgroup HIV-infected HIV-uninfected men main cohort measure daily physical activity use activity tracker .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Group 1 : HIV positive subject HIV positive English speaking 5065 year old On Antiretroviral therapy HIV viral load 200 copies/ml CD4 equal great 350 cells/mm3 Postmenopausal ( woman ) Lower extremity mobility sufficient participate functional assessment . Group 2 : HIV negative subject Inclusion Criteria Group 2 subject English speaking 5065 year old Negative HIV ( base HIV antibody test Study Visit 1 ) Matched Group 1 sex ( 50 % W , 50 % M ) age ( 50 65yo ) Postmenopausal ( woman ) Lower extremity mobility sufficient participate functional assessment . Exclusion Criteria Group 1 Subjects Acute serious illness within 60 day prior entry Use pharmacologic dos corticosteroid past 6 month . Use anabolic therapy past 6 month . Lower extremity mobility insufficient participate functional assessment . Current use ( last 30 day ) anticoagulant know bleed disorder . Exclusion Criteria Group 2 subject Acute serious illness within 60 day prior entry Use pharmacologic dos corticosteroid past 6 month Use anabolic therapy past 6 month Lower extremity mobility insufficient participate functional assessment Current use ( last 30 day ) anticoagulant know bleed disorder .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>